SPASFON LYOC 80 mg, lyophilizate oral 10 oral lyophilisates
Active ingredients: Anhydrous phloroglucinol, Phloroglucinol dihydrate
Commercialized according to BDPM
Lyophilizate10 oral lyophilisatesorale;sublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPASFON LYOC 80 mg, lyophilisat oral
- Pharmaceutical form
- lyophilisat
- Route of administration
- orale;sublinguale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 10 lyophilisat(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1978
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62944693CIP73186301CIP133400931863014Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHLOROGLUCINOL HYDRATÉlyophilisat | 80 mg · un lyophilisat | SA |
| PHLOROGLUCINOL ANHYDRElyophilisat | 62,25 mg · un lyophilisat | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.